Robin Lachmann

11.1k citations

129 papers · 6.3k indexed · 4 hit papers · h-index 43

Impact in

Physiology top 0.5%
- Lysosomal Storage Disorders Research
Cell Biology top 1%
- Cellular transport and secretion

Papers in ⓘ

Physiology 71
- Lysosomal Storage Disorders Research 65
Molecular Biology 38

Co-authors: Frances M. Platt (11 shared papers)Elaine Murphy (32 shared papers)Timothy M. Cox (9 shared papers)Derralynn Hughes (18 shared papers)Stacey Efstathiou (10 shared papers)Raymond A. Dwek (5 shared papers)Terry D. Butters (5 shared papers)Atul Mehta (9 shared papers)
Journals: Journal of Inherited Metabolic Disease (20 papers)Molecular Genetics and Metabolism (10 papers)Orphanet Journal of Rare Diseases (7 papers)Movement Disorders (3 papers)Journal of General Virology (3 papers)
Partner nations: United Kingdom Netherlands Germany

In The Last Decade

Robin Lachmann

120 papers receiving 6.2k citations

Hit Papers

align trajectories log scale

Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping 2013 · 365 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Circulation Cardiovascular Imaging
2010 The Lancet
2009 Brain
2000 The Lancet

Peers

Countries citing papers authored by Robin Lachmann

Since Specialization

Citations

This map shows the geographic impact of Robin Lachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Lachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Lachmann more than expected).

Fields of papers citing papers by Robin Lachmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Lachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Lachmann. The network helps show where Robin Lachmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin Lachmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin Lachmann Line = papers co-authored together Robin Lachmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial The Lancet ·Frederick J. Raal, Raúl D. Santos, Dirk Blom, A. David Marais, Min‐Ji Charng, William C. Cromwell, Robin Lachmann, Daniel Gaudet, Ju Le Tan, Scott Chasan-Taber, Diane L. Tribble, JoAnn Flaim, Stanley T. Crooke Hit paper breakdown →	2010	692
2	Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis The Lancet ·Timothy M. Cox, Robin Lachmann, C. E. Hollak, Johannes M. F. G. Aerts, Sonja van Weely, Martin Hřebı́ček, Frances M. Platt, Terry D. Butters, Raymond A. Dwek, Chris Moyses, Irene Gow, Deborah Elstein, Ari Zimran Hit paper breakdown →	2000	592
3	Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease Brain ·Juliane Neumann, José Brás, Emma Deas, Sean S. O’Sullivan, Laura Parkkinen, Robin Lachmann, Abi Li, Janice L. Holton, Rita Guerreiro, Reema Paudel, Badmavady Segarane, Andrew Singleton, Andrew J. Lees, John Hardy, Henry Houlden, Tamás Révész, Nicholas Wood Hit paper breakdown →	2009	509
4	Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping Circulation Cardiovascular Imaging ·Daniel Sado, Steven K White, Stefan K. Piechnik, Sanjay M Banypersad, Thomas A. Treibel, Gabriella Captur, Marianna Fontana, Viviana Maestrini, Andrew Flett, Matthew D. Robson, Robin Lachmann, Elaine Murphy, Atul Mehta, Derralynn Hughes, Stefan Neubauer, Perry Elliott, James Moon Hit paper breakdown →	2013	365
5	Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease Heart ·Daniel Sado, Andrew Flett, Sanjay M Banypersad, Steven K White, Viviana Maestrini, Giovanni Quarta, Robin Lachmann, Elaine Murphy, Atul Mehta, Derralynn Hughes, William J. McKenna, Andrew M. Taylor, Derek J. Hausenloy, Philip N. Hawkins, Perry Elliott, James Moon	2012	257
6	Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease Journal of Medical Genetics ·Dominique P. Germain, Joel Charrow, Robert J. Desnick, Nathalie Guffon, Judy Kempf, Robin Lachmann, Roberta Lemay, Gabor E. Linthorst, Seymour Packman, C. Ronald Scott, Stephen Waldek, David G. Warnock, Neal J. Weinreb, William R. Wilcox	2015	253
7	Sustained therapeutic effects of oral miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) in type I Gaucher disease Journal of Inherited Metabolic Disease ·Deborah Elstein, Carla E. M. Hollak, Johannes M. F. G. Aerts, Sonja van Weely, Mario Maas, Timothy M. Cox, Robin Lachmann, (unknown), Frances M. Platt, Terry D. Butters, Raymond A. Dwek, Ari Zimran	2004	193
8	Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance Journal of Cardiovascular Magnetic Resonance ·Silvia Pica, Daniel Sado, Viviana Maestrini, Marianna Fontana, Steven K White, Thomas A. Treibel, Gabriella Captur, Sarah Anderson, Stefan K. Piechnik, Matthew D. Robson, Robin Lachmann, Elaine Murphy, Atul Mehta, Derralynn Hughes, Peter Kellman, Perry Elliott, Anna S Herrey, James Moon	2014	142
9	Treatment with miglustat reverses the lipid-trafficking defect in Niemann–Pick disease type C Neurobiology of Disease ·Robin Lachmann, Daniëlle te Vruchte, Emyr Lloyd‐Evans, Gabriele Reinkensmeier, Daniel J. Sillence, Luisa Fernandez-Guillen, Raymond A. Dwek, Terry D. Butters, Timothy M. Cox, Frances M. Platt	2004	121
10	Twin pairs showing discordance of phenotype in adult Gaucher's disease QJM ·Robin Lachmann, Irene R. Grant, David Halsall, Timothy M. Cox	2004	119
11	Enzyme replacement therapy for lysosomal storage diseases Current Opinion in Pediatrics ·Robin Lachmann	2011	108
12	European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10‐year experience European Journal of Neurology ·Ans T. van der Ploeg, Michelle E. Kruijshaar, António Toscano, Pascal Laforêt, C. Angelini, Robin Lachmann, Samuel Ignacio Pascual Pascual, Mark Roberts, Kai M. Rösler, Thomas M. Stulnig, Pieter A. van Doorn, Peter Van den Bergh, John Vissing, Benedikt Schoser	2017	107
13	Proposed Stages of Myocardial Phenotype Development in Fabry Disease JACC. Cardiovascular imaging ·Sabrina Nordin, Rebecca Kozor, Katia Menacho, Amna Abdel‐Gadir, Shanat Baig, Daniel Sado, Ilaria Lobascio, Elaine Murphy, Robin Lachmann, Atul Mehta, Nicola C. Edwards, Uma Ramaswami, Richard P. Steeds, Derralynn Hughes, James Moon	2018	104
14	The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders. Health Technology Assessment ·Katrina Wyatt, William Henley, Lindsey Anderson, Rob Anderson, Vasilis Nikolaou, Kerstin Stein, L Klinger, Derralynn Hughes, S. Waldek, Robin Lachmann, Atul Mehta, Ashok Vellodi, Stuart Logan	2012	102
15	Outcome of adult patients with X‐linked hypophosphatemia caused by PHEX gene mutations Journal of Inherited Metabolic Disease ·Douglas Chesher, Michael Oddy, Ulpee Darbar, Parag Sayal, Adrian T. H. Casey, Aidan Ryan, Annalisa Sechi, Charlotte Simister, Aoife Waters, Yehani Wedatilake, Robin Lachmann, Elaine Murphy	2018	98
16	Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy Journal of Inherited Metabolic Disease ·Frances M. Platt, Mylvaganam Jeyakumar, Ulrika Andersson‐Hall, David A. Priestman, Raymond A. Dwek, Terry D. Butters, Timothy M. Cox, Robin Lachmann, Carla E. M. Hollak, Johannes M. F. G. Aerts, Sonja van Weely, (unknown), Chris Moyses, Iain F Gow, Deborah Elstein, Ari Zimran	2001	92
17	Depression in adults with Fabry disease: A common and under‐diagnosed problem Journal of Inherited Metabolic Disease ·Ashley L. Cole, P. J. Lee, Derralynn Hughes, Patrick Deegan, S. Waldek, Robin Lachmann	2007	83
18	Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months Journal of Inherited Metabolic Disease ·Melissa Wasserstein, George A. Díaz, Robin Lachmann, Marie‐Hélène Jouvin, Indrani Nandy, Allena Ji, Ana Cristina Puga	2018	80
19	Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system Journal of Virology ·Robin Lachmann, Stacey Efstathiou	1997	79
20	Clinical and genetic predictors of major cardiac events in patients with Anderson–Fabry Disease Heart ·Vimal Patel, Constantinos O’Mahony, Derralynn Hughes, Mohammad Shafiqur Rahman, Caroline Coats, Elaine Murphy, Robin Lachmann, Atul Mehta, Perry Elliott	2015	76

About Robin Lachmann

Robin Lachmann is a scholar working on Physiology, Molecular Biology, Epidemiology, Rheumatology and Clinical Biochemistry, having authored 129 papers that have together received 6.3k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (65 papers), Metabolism and Genetic Disorders (22 papers), Trypanosoma species research and implications (22 papers), Glycogen Storage Diseases and Myoclonus (18 papers), Cellular transport and secretion (15 papers), Carbohydrate Chemistry and Synthesis (12 papers), Herpesvirus Infections and Treatments (11 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Physiology (3.4k citations), Cell Biology (1.2k citations), Clinical Biochemistry (426 citations), Rheumatology (744 citations) and Physiology (213 citations). Robin Lachmann has collaborated with scholars based in United Kingdom, Netherlands and Germany. Frequent co-authors include Frances M. Platt, Elaine Murphy, Timothy M. Cox, Derralynn Hughes, Stacey Efstathiou, Raymond A. Dwek, Terry D. Butters, Atul Mehta, Perry Elliott and Ari Zimran. Their work appears in journals such as Journal of Inherited Metabolic Disease, Molecular Genetics and Metabolism, Orphanet Journal of Rare Diseases, Movement Disorders and Journal of General Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact